phenylpropanolamine has been researched along with Xerostomia in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 19 (79.17) | 29.6817 |
| 2010's | 4 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blauwet, MB; Chapple, CR; Huang, M; Kaplan, SA; Khullar, V; Mitcheson, D; Siddiqui, E | 1 |
| Brunocilla, E; Carini, M; De Nunzio, C; Gacci, M; Gravas, S; Novara, G; Oelke, M; Salvi, M; Schiavina, R; Sebastianelli, A; Serni, S; Tubaro, A | 1 |
| Li, J; Li, P; Liu, B; Wang, Y; Wu, Y | 1 |
| Brum, J; Ebinger, U; Egermark, M; Olshansky, B; Rekeda, L; Viegas, A | 1 |
| Chapple, CR; Cummings, J; Dorrepaal, C; Drogendijk, T; Kaplan, SA; Klecka, J; Martin, N; Mitcheson, D | 1 |
| Appell, RA | 1 |
| Xiao, Z | 1 |
| Bang, LM; Easthope, SE; Perry, CM | 1 |
| Hill, S; Jonas, U; Khullar, V; Laval, KU; Schiøtz, HA; Versi, E | 1 |
| Bard, RJ; Casey, AR; Ethans, KD; Nance, PW; Schryvers, OI | 1 |
| Sand, PK | 1 |
| Chen, MF; Lin, LS; Song, J; Song, YF | 1 |
| Armstrong, RB; Luber, KM; Peters, KM | 1 |
| Kripke, C | 1 |
| Appell, RA; Bavendam, T; Dmochowski, R; Guan, Z; Nitti, VW; Wang, JT | 1 |
| Alken, P; Jünemann, KP; Scheepe, JR; van den Hoek, J | 1 |
| Mitova, E | 1 |
| Albrecht, D; Anderson, R; Appell, RA; Boone, T; Dmochowski, R; Lama, D; Miklos, J; Roach, M; Saltzstein, D; Sand, P; Staskin, DR; Zinner, N | 1 |
| Malone-Lee, JG; Maugourd, MF; Walsh, JB | 1 |
| Crandall, C | 1 |
| Mattiasson, A; Stanton, SL; Zinner, NR | 1 |
6 review(s) available for phenylpropanolamine and Xerostomia
| Article | Year |
|---|---|
Tolterodine extended release in the treatment of male OAB/storage LUTS: a systematic review.
Topics: Adrenergic alpha-Antagonists; Benzhydryl Compounds; Constipation; Cresols; Delayed-Action Preparations; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urological Agents; Xerostomia | 2014 |
[Comparisons of therapeutic efficacy and safety of solifenacin versus tolterodine in patients with overactive bladder: a meta-analysis of outcomes].
Topics: Benzhydryl Compounds; Constipation; Cresols; Humans; Phenylpropanolamine; Quinuclidines; Safety; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Xerostomia | 2014 |
The newer antimuscarinic drugs: bladder control with less dry mouth.
Topics: Benzhydryl Compounds; Controlled Clinical Trials as Topic; Cresols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Time Factors; Tolterodine Tartrate; Urinary Incontinence; Xerostomia | 2002 |
Elevating our therapeutic expectations in overactive bladder.
Topics: Benzhydryl Compounds; Benzilates; Benzofurans; Constipation; Cresols; Delayed-Action Preparations; Humans; Mandelic Acids; Muscarinic Antagonists; Nortropanes; Phenylpropanolamine; Pyrrolidines; Quinuclidines; Solifenacin Succinate; Tetrahydroisoquinolines; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence; Vision Disorders; Xerostomia | 2004 |
Anticholinergic drugs for overactive bladder.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Delayed-Action Preparations; Humans; Mandelic Acids; Phenylpropanolamine; Tolterodine Tartrate; Urinary Incontinence; Xerostomia | 2006 |
Tolterodine: a clinical review.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Cresols; Dose-Response Relationship, Drug; Humans; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Randomized Controlled Trials as Topic; Tolterodine Tartrate; Urinary Incontinence; Xerostomia | 2001 |
13 trial(s) available for phenylpropanolamine and Xerostomia
| Article | Year |
|---|---|
Mirabegron 50 mg once-daily for the treatment of symptoms of overactive bladder: an overview of efficacy and tolerability over 12 weeks and 1 year.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Drug Administration Schedule; Female; Headache; Humans; Hypertension; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Thiazoles; Tolterodine Tartrate; Urinary Bladder, Overactive; Urinary Retention; Urinary Tract Infections; Urination; Xerostomia | 2014 |
Differential pharmacological effects of antimuscarinic drugs on heart rate: a randomized, placebo-controlled, double-blind, crossover study with tolterodine and darifenacin in healthy participants > or = 50 years.
Topics: Age Factors; Aged; Aged, 80 and over; Benzhydryl Compounds; Benzofurans; Constipation; Cresols; Cross-Over Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Electrocardiography; Female; Heart Rate; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Pyrrolidines; Time Factors; Tolterodine Tartrate; Xerostomia | 2008 |
Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder.
Topics: Acetanilides; Adrenergic beta-3 Receptor Agonists; Aged; Benzhydryl Compounds; Constipation; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Headache; Humans; Hypertension; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Single-Blind Method; Thiazoles; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Overactive; Urinary Incontinence, Urge; Urinary Retention; Xerostomia | 2013 |
[An open label multi-center clinical trial to evaluate the efficacy of compound pseudoephedrine [corrected] hydrochloride sustained release capsules in patients with nasal symptoms associated with common cold].
Topics: Adolescent; Adult; Aged; Common Cold; Delayed-Action Preparations; Female; Humans; Influenza, Human; Male; Middle Aged; Nasal Decongestants; Nasal Obstruction; Phenylpropanolamine; Sleep Wake Disorders; Sneezing; Treatment Outcome; Xerostomia | 2002 |
Transdermal oxybutynin: for overactive bladder.
Topics: Administration, Cutaneous; Administration, Oral; Adult; Aged; Benzhydryl Compounds; Cresols; Double-Blind Method; Exanthema; Humans; Mandelic Acids; Middle Aged; Phenylpropanolamine; Time Factors; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence; Xerostomia | 2003 |
Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
Topics: Adult; Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Diuresis; Double-Blind Method; Female; Humans; Middle Aged; Muscarinic Antagonists; Patient Acceptance of Health Care; Phenylpropanolamine; Quality of Life; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence; Urinary Incontinence, Stress; Urination; Xerostomia | 2004 |
Efficacy and safety of tolterodine in people with neurogenic detrusor overactivity.
Topics: Adult; Benzhydryl Compounds; Cresols; Cross-Over Studies; Double-Blind Method; Female; Humans; Male; Mandelic Acids; Middle Aged; Multiple Sclerosis; Muscarinic Antagonists; Phenylpropanolamine; Prospective Studies; Spinal Cord Injuries; Tolterodine Tartrate; Urinary Bladder, Neurogenic; Urinary Incontinence; Xerostomia | 2004 |
[A clinical study of pelvic floor electrical stimulation in treatment of overactive bladder].
Topics: Adult; Aged; Benzhydryl Compounds; Constipation; Cresols; Electric Stimulation Therapy; Female; Humans; Middle Aged; Pelvic Floor; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence; Urination; Urination Disorders; Xerostomia | 2004 |
Comparison of dry mouth in women treated with extended-release formulations of oxybutynin or tolterodine for overactive bladder.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Humans; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Severity of Illness Index; Tolterodine Tartrate; Urinary Incontinence; Xerostomia | 2005 |
Efficacy and tolerability of tolterodine extended-release in continent patients with overactive bladder and nocturia.
Topics: Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Constipation; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Treatment Outcome; Urination Disorders; Urodynamics; Xerostomia | 2006 |
Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of overactive bladder: results of the OBJECT Study.
Topics: Aged; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Male; Mandelic Acids; Middle Aged; Muscarinic Antagonists; Nervous System Diseases; Phenylpropanolamine; Probability; Prospective Studies; Reference Values; Severity of Illness Index; Statistics, Nonparametric; Tartrates; Tolterodine Tartrate; Treatment Outcome; Urinary Bladder, Neurogenic; Urinary Incontinence, Stress; Urination Disorders; Xerostomia | 2001 |
Tolterodine: a safe and effective treatment for older patients with overactive bladder.
Topics: Age Factors; Aged; Aged, 80 and over; Benzhydryl Compounds; Cresols; Double-Blind Method; Drug Monitoring; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Placebos; Safety; Tolterodine Tartrate; Treatment Outcome; Urinary Incontinence; Urination Disorders; Xerostomia | 2001 |
Efficacy, safety, and tolerability of extended-release once-daily tolterodine treatment for overactive bladder in older versus younger patients.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Benzhydryl Compounds; Cohort Studies; Cresols; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Male; Middle Aged; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence; Xerostomia | 2002 |
5 other study(ies) available for phenylpropanolamine and Xerostomia
| Article | Year |
|---|---|
Oxybutynin transdermal (Oxytrol) for overactive bladder.
Topics: Administration, Cutaneous; Administration, Oral; Benzhydryl Compounds; Cresols; Delayed-Action Preparations; Humans; Mandelic Acids; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Xerostomia | 2003 |
A standardised mini pig model for in vivo investigations of anticholinergic effects on bladder function and salivation.
Topics: Animals; Atropine; Benzhydryl Compounds; Benzilates; Blood Pressure; Cholinergic Antagonists; Cresols; Drug Evaluation, Preclinical; Electric Stimulation; Heart Rate; Lingual Nerve; Male; Models, Animal; Muscle Contraction; Phenylpropanolamine; Reproducibility of Results; Salivary Glands; Salivation; Swine; Swine, Miniature; Tolterodine Tartrate; Urinary Bladder; Xerostomia | 2007 |
Tolterodine for overactive bladder.
Topics: Benzhydryl Compounds; Clinical Trials as Topic; Cresols; Double-Blind Method; Humans; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Urination Disorders; Xerostomia | 1998 |
[Detrusitol - a drug of choice in impaired function of the bladder and urinary incontinence].
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Benzhydryl Compounds; Child; Child, Preschool; Cresols; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Urinary Incontinence; Xerostomia | 2000 |
Detrol LA and Diropan XL for overactive bladder.
Topics: Benzhydryl Compounds; Cholinergic Antagonists; Clinical Trials as Topic; Cresols; Delayed-Action Preparations; Female; Headache; Humans; Male; Mandelic Acids; Muscarinic Antagonists; Phenylpropanolamine; Tolterodine Tartrate; Urinary Bladder Diseases; Urination Disorders; Xerostomia | 2001 |